Dextropropoxyphene Napsylate from Japan
Dextropropoxyphene napsylate is a water-soluble salt of dextropropoxyphene, formerly used in combination pain medications like Darvon-N. Classified under HTS 2922.14.00.00 due to chapter notes specifying salts of this INN compound as oxygen-function amino-alcohols.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify salt identity via HPLC testing to distinguish from hydrochloride and ensure correct HTS classification
• File prior notice with FDA for chemical imports and monitor DEA scheduling (now Schedule II equivalent)
• Avoid bulk packaging over stabilizer limits per chapter note (f) to prevent reclassification as mixtures